134 related articles for article (PubMed ID: 34952451)
21. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
[TBL] [Abstract][Full Text] [Related]
22. Forty-Three Fatalities Involving the Synthetic Cannabinoid, 5-Fluoro-ADB: Forensic Pathology and Toxicology Implications.
Boland DM; Reidy LJ; Seither JM; Radtke JM; Lew EO
J Forensic Sci; 2020 Jan; 65(1):170-182. PubMed ID: 31211877
[TBL] [Abstract][Full Text] [Related]
23. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature.
Ozturk HM; Yetkin E; Ozturk S
Cardiovasc Toxicol; 2019 Jun; 19(3):191-197. PubMed ID: 31030341
[TBL] [Abstract][Full Text] [Related]
25. Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer.
Nacca N; Schult R; Loflin R; Weltler A; Gorodetsky R; Kacinko S; Moran J; Krotulski A; Wiegand T
J Emerg Med; 2018 Dec; 55(6):788-791. PubMed ID: 30297193
[TBL] [Abstract][Full Text] [Related]
26. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
[TBL] [Abstract][Full Text] [Related]
27. AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.
Maeda H; Kikura-Hanajiri R; Kawamura M; Nagashima E; Yoshida KI
Clin Toxicol (Phila); 2018 Feb; 56(2):143-145. PubMed ID: 28707493
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
29. Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Feb; 81(24):6175-7. PubMed ID: 26859904
[TBL] [Abstract][Full Text] [Related]
30. Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model.
Hsin-Hung Chen M; Dip A; Ahmed M; Tan ML; Walterscheid JP; Sun H; Teng BB; Mozayani A
J Cell Biochem; 2016 Apr; 117(4):1033-43. PubMed ID: 26517302
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel bromoindazole synthetic cannabinoid analogue in seized e-cigarette liquid: ADB-BRINACA.
Choi H; Kim S; Jang H; Kim HJ; Choe S
Forensic Sci Int; 2022 Sep; 338():111385. PubMed ID: 35863161
[TBL] [Abstract][Full Text] [Related]
32. Fatalities related to new psychoactive substances in Singapore-A case series.
Chan S; Wu J; Lee B
Forensic Sci Int; 2019 Nov; 304():109892. PubMed ID: 31395407
[TBL] [Abstract][Full Text] [Related]
33. The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017.
Somerville RF; Hassan VR; Kolbe E; Partington HK; Walsh KAJ; Kappatos DC; Johnson CS
Forensic Sci Int; 2019 Jul; 300():19-27. PubMed ID: 31063884
[TBL] [Abstract][Full Text] [Related]
34. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
Göl E; Çok İ
Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
[TBL] [Abstract][Full Text] [Related]
35. The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
Trexler KR; Vanegas SO; Poklis JL; Kinsey SG
Drug Alcohol Depend; 2020 Sep; 214():108179. PubMed ID: 32688070
[TBL] [Abstract][Full Text] [Related]
36. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
[TBL] [Abstract][Full Text] [Related]
37. A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP.
Yamagishi I; Minakata K; Nozawa H; Hasegawa K; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
Leg Med (Tokyo); 2018 Nov; 35():44-49. PubMed ID: 30268690
[TBL] [Abstract][Full Text] [Related]
38. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
Noble C; Cannaert A; Linnet K; Stove CP
Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
[TBL] [Abstract][Full Text] [Related]
39. Mono-/polyintoxication with 5F-ADB: A case series.
Kraemer M; Fels H; Dame T; Musshoff F; Halter S; Mogler L; Hess C; Madea B; Maas A
Forensic Sci Int; 2019 Aug; 301():e29-e37. PubMed ID: 31138461
[TBL] [Abstract][Full Text] [Related]
40. Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.
Oliveira da Cruz JF; Ioannidou C; Pagano Zottola AC; Muguruza C; Gomez-Sotres P; Fernandez M; Callado LF; Marsicano G; Busquets-Garcia A
Addict Biol; 2021 May; 26(3):e12940. PubMed ID: 32744799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
